Autism Spectrum Disorder (ASD) can be described as a “group of developmental disabilities that can cause significant social, communication and behavioral challenges“. The epidemiological data presented by the CDC reported that 1 in 68 children are currently diagnosed with ASD (CDC, 2016). The CDC has noted an increase in the prevalence of ASD since the 1990’s, making effective treatment an important part of the growing conversation. Providing effective treatment options is becoming more and more crucial for this population, especially when considering the cost of healthcare for these individuals. With rates of incidence rising, this condition has become a major health care crisis calling for effective methods of intervention and an intimate understanding of the disorder. Neurofeedback is one promising method to treat the symptoms of ASD (Coben, 2013). This presentation will focus on providing up to date information on the clinical, neurophysiological and neuropsychological underpinnings for individuals with Autism Spectrum Disorders (ASD) and how to use this information for better treatment plans and improved outcomes.
This presentation will discuss the importance of considering ASD in the context of underlying neurophysiological and neurocognitive correlates. When considering a treatment plan, this information can be used to rate the baseline symptoms in objective manner, as well as, objectively measure change through the treatment course. This approach also allows the clinician more information to use to make adjustments during the treatment process. It is apparent that an optimal treatment course, will demonstrate measurable change, at the subjective, neurophysiological and neurocogntive/behavioral levels of analysis.
This presentation will outline assessment opportunities, for various mental health professionals to consider adding to their own practice. Further discussion will related this information to the EEG analysis. Next, steps will be provided regarding using the information for establishing the neurofeedback protocol. The presentation will provide a basic foundation for assessment opportunities for the neurofeedback clinician and strategies on how to use this information to make a more informed choice about neurofeedback treatment protocols. Using this information to measure outcome goals will also be discussed. Case presentations will also be provided to further a practical understanding.
